Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
about
BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.A correlation analysis between tumor imaging changes and p-AKT and HSP70 expression in tumor cells after osteosarcoma chemotherapy.Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.Progress in the chemotherapeutic treatment of osteosarcoma
P2860
Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@en
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@nl
type
label
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@en
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@nl
prefLabel
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@en
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@nl
P2093
P2860
P356
P1476
Higher Gemcitabine Dose Was As ...... tabine-Docetaxel Chemotherapy.
@en
P2093
Byung Kiu Park
Dae-Geun Jeon
Hee Jo Baek
Hee Young Shin
Ho Joon Im
Hoi Soo Yoon
Hong Hoe Koo
Hyeon Jin Park
Hyo Seop Ahn
P2860
P304
P356
10.1002/PBC.26058
P577
2016-05-16T00:00:00Z